Skip to main content
. 2019 Sep 26;55(5):1033–1048. doi: 10.3892/ijo.2019.4886

Figure 5.

Figure 5

CEA from NSCLC associates with sLex/sLea and has reactivity with E-selectin. (A) Western blot analysis of tumour lysates from CEA-positive NSCLC tissues. CEA-positive NSCLC tissues were resolved via SDS-PAGE and immunoblotted with HECA-452 mAb, E-Ig and anti-CEA mAb. (B) Western blot analysis of immunoprecipitated CEA. CEA was immunoprecipitated from the tumour lysate of patient 7, and then resolved via SDS-PAGE and blotted. Left, HECA-452 staining; middle, E-Ig staining; right, anti-CEA mAb staining. CEA, carcinoembryonic antigen; E-Ig, mouse E-selectin-human Fc Ig chimera; HECA, HECA-452; IP, immunoprecipitation; mAb, monoclonal antibody; NSCLC, non-small cell lung cancer; sLea/x, sialyl Lewis a/x.